nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ABCB1—hematologic cancer	0.206	1	CbGaD
Neostigmine—ACHE—Irinotecan—hematologic cancer	0.0757	0.148	CbGbCtD
Neostigmine—BCHE—Triamcinolone—hematologic cancer	0.0602	0.118	CbGbCtD
Neostigmine—BCHE—Irinotecan—hematologic cancer	0.0456	0.0892	CbGbCtD
Neostigmine—ABCB1—Lenalidomide—hematologic cancer	0.0413	0.0807	CbGbCtD
Neostigmine—BCHE—Cisplatin—hematologic cancer	0.0372	0.0727	CbGbCtD
Neostigmine—ABCB1—Daunorubicin—hematologic cancer	0.0242	0.0473	CbGbCtD
Neostigmine—ABCB1—Alitretinoin—hematologic cancer	0.0237	0.0463	CbGbCtD
Neostigmine—ABCB1—Imatinib—hematologic cancer	0.0185	0.0362	CbGbCtD
Neostigmine—ABCB1—Nilotinib—hematologic cancer	0.0168	0.0329	CbGbCtD
Neostigmine—ABCB1—Vinorelbine—hematologic cancer	0.0167	0.0326	CbGbCtD
Neostigmine—ABCB1—Dasatinib—hematologic cancer	0.0149	0.0291	CbGbCtD
Neostigmine—ABCB1—Mitoxantrone—hematologic cancer	0.0147	0.0287	CbGbCtD
Neostigmine—ABCB1—Betamethasone—hematologic cancer	0.0131	0.0256	CbGbCtD
Neostigmine—ABCB1—Gemcitabine—hematologic cancer	0.013	0.0254	CbGbCtD
Neostigmine—ABCB1—Prednisolone—hematologic cancer	0.0129	0.0253	CbGbCtD
Neostigmine—ABCB1—Prednisone—hematologic cancer	0.0122	0.0239	CbGbCtD
Neostigmine—ABCB1—Irinotecan—hematologic cancer	0.0116	0.0226	CbGbCtD
Neostigmine—ABCB1—Vinblastine—hematologic cancer	0.0103	0.0201	CbGbCtD
Neostigmine—ABCB1—Vincristine—hematologic cancer	0.0101	0.0198	CbGbCtD
Neostigmine—ABCB1—Cisplatin—hematologic cancer	0.00944	0.0184	CbGbCtD
Neostigmine—ABCB1—Etoposide—hematologic cancer	0.00927	0.0181	CbGbCtD
Neostigmine—ABCB1—Dexamethasone—hematologic cancer	0.00762	0.0149	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—hematologic cancer	0.00632	0.0124	CbGbCtD
Neostigmine—ABCB1—Methotrexate—hematologic cancer	0.00613	0.012	CbGbCtD
Neostigmine—Drowsiness—Doxorubicin—hematologic cancer	6.68e-05	0.000305	CcSEcCtD
Neostigmine—Headache—Carmustine—hematologic cancer	6.65e-05	0.000304	CcSEcCtD
Neostigmine—Shock—Betamethasone—hematologic cancer	6.65e-05	0.000304	CcSEcCtD
Neostigmine—Shock—Dexamethasone—hematologic cancer	6.65e-05	0.000304	CcSEcCtD
Neostigmine—Dyspnoea—Triamcinolone—hematologic cancer	6.64e-05	0.000304	CcSEcCtD
Neostigmine—Rash—Alitretinoin—hematologic cancer	6.63e-05	0.000303	CcSEcCtD
Neostigmine—Nervous system disorder—Betamethasone—hematologic cancer	6.63e-05	0.000303	CcSEcCtD
Neostigmine—Nervous system disorder—Dexamethasone—hematologic cancer	6.63e-05	0.000303	CcSEcCtD
Neostigmine—Agitation—Prednisone—hematologic cancer	6.63e-05	0.000303	CcSEcCtD
Neostigmine—Dermatitis—Alitretinoin—hematologic cancer	6.63e-05	0.000303	CcSEcCtD
Neostigmine—Vomiting—Ifosfamide—hematologic cancer	6.61e-05	0.000302	CcSEcCtD
Neostigmine—Hypersensitivity—Cisplatin—hematologic cancer	6.6e-05	0.000302	CcSEcCtD
Neostigmine—Tachycardia—Betamethasone—hematologic cancer	6.59e-05	0.000302	CcSEcCtD
Neostigmine—Tachycardia—Dexamethasone—hematologic cancer	6.59e-05	0.000302	CcSEcCtD
Neostigmine—Bradycardia—Epirubicin—hematologic cancer	6.59e-05	0.000302	CcSEcCtD
Neostigmine—Headache—Alitretinoin—hematologic cancer	6.59e-05	0.000301	CcSEcCtD
Neostigmine—Diarrhoea—Gemcitabine—hematologic cancer	6.58e-05	0.000301	CcSEcCtD
Neostigmine—Nausea—Thalidomide—hematologic cancer	6.57e-05	0.0003	CcSEcCtD
Neostigmine—Rash—Ifosfamide—hematologic cancer	6.55e-05	0.0003	CcSEcCtD
Neostigmine—Dermatitis—Ifosfamide—hematologic cancer	6.55e-05	0.0003	CcSEcCtD
Neostigmine—Hyperhidrosis—Dexamethasone—hematologic cancer	6.53e-05	0.000299	CcSEcCtD
Neostigmine—Hyperhidrosis—Betamethasone—hematologic cancer	6.53e-05	0.000299	CcSEcCtD
Neostigmine—Dizziness—Irinotecan—hematologic cancer	6.53e-05	0.000299	CcSEcCtD
Neostigmine—Urticaria—Etoposide—hematologic cancer	6.52e-05	0.000298	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—hematologic cancer	6.49e-05	0.000297	CcSEcCtD
Neostigmine—Syncope—Prednisone—hematologic cancer	6.47e-05	0.000296	CcSEcCtD
Neostigmine—Vomiting—Vincristine—hematologic cancer	6.44e-05	0.000295	CcSEcCtD
Neostigmine—Urticaria—Prednisolone—hematologic cancer	6.43e-05	0.000294	CcSEcCtD
Neostigmine—Asthenia—Cisplatin—hematologic cancer	6.43e-05	0.000294	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—hematologic cancer	6.4e-05	0.000293	CcSEcCtD
Neostigmine—Rash—Vincristine—hematologic cancer	6.39e-05	0.000292	CcSEcCtD
Neostigmine—Dermatitis—Vincristine—hematologic cancer	6.38e-05	0.000292	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—hematologic cancer	6.37e-05	0.000291	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—hematologic cancer	6.35e-05	0.00029	CcSEcCtD
Neostigmine—Headache—Vincristine—hematologic cancer	6.35e-05	0.00029	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisone—hematologic cancer	6.34e-05	0.00029	CcSEcCtD
Neostigmine—Hypotension—Dexamethasone—hematologic cancer	6.31e-05	0.000289	CcSEcCtD
Neostigmine—Hypotension—Betamethasone—hematologic cancer	6.31e-05	0.000289	CcSEcCtD
Neostigmine—Nausea—Carmustine—hematologic cancer	6.31e-05	0.000288	CcSEcCtD
Neostigmine—Vomiting—Irinotecan—hematologic cancer	6.28e-05	0.000287	CcSEcCtD
Neostigmine—Vomiting—Mitoxantrone—hematologic cancer	6.28e-05	0.000287	CcSEcCtD
Neostigmine—Nausea—Alitretinoin—hematologic cancer	6.25e-05	0.000286	CcSEcCtD
Neostigmine—Convulsion—Prednisone—hematologic cancer	6.25e-05	0.000286	CcSEcCtD
Neostigmine—Mediastinal disorder—Methotrexate—hematologic cancer	6.24e-05	0.000285	CcSEcCtD
Neostigmine—Rash—Mitoxantrone—hematologic cancer	6.22e-05	0.000285	CcSEcCtD
Neostigmine—Rash—Irinotecan—hematologic cancer	6.22e-05	0.000285	CcSEcCtD
Neostigmine—Dermatitis—Irinotecan—hematologic cancer	6.22e-05	0.000284	CcSEcCtD
Neostigmine—Dermatitis—Mitoxantrone—hematologic cancer	6.22e-05	0.000284	CcSEcCtD
Neostigmine—Headache—Mitoxantrone—hematologic cancer	6.18e-05	0.000283	CcSEcCtD
Neostigmine—Headache—Irinotecan—hematologic cancer	6.18e-05	0.000283	CcSEcCtD
Neostigmine—Nausea—Ifosfamide—hematologic cancer	6.17e-05	0.000282	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.16e-05	0.000282	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.16e-05	0.000282	CcSEcCtD
Neostigmine—Arthralgia—Prednisone—hematologic cancer	6.14e-05	0.000281	CcSEcCtD
Neostigmine—Diarrhoea—Cisplatin—hematologic cancer	6.13e-05	0.00028	CcSEcCtD
Neostigmine—Vomiting—Gemcitabine—hematologic cancer	6.11e-05	0.00028	CcSEcCtD
Neostigmine—Insomnia—Dexamethasone—hematologic cancer	6.11e-05	0.00028	CcSEcCtD
Neostigmine—Insomnia—Betamethasone—hematologic cancer	6.11e-05	0.00028	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—hematologic cancer	6.1e-05	0.000279	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.1e-05	0.000279	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—hematologic cancer	6.06e-05	0.000277	CcSEcCtD
Neostigmine—Rash—Gemcitabine—hematologic cancer	6.06e-05	0.000277	CcSEcCtD
Neostigmine—Dermatitis—Gemcitabine—hematologic cancer	6.06e-05	0.000277	CcSEcCtD
Neostigmine—Hypersensitivity—Etoposide—hematologic cancer	6.05e-05	0.000277	CcSEcCtD
Neostigmine—Headache—Gemcitabine—hematologic cancer	6.02e-05	0.000275	CcSEcCtD
Neostigmine—Nausea—Vincristine—hematologic cancer	6.02e-05	0.000275	CcSEcCtD
Neostigmine—Flushing—Epirubicin—hematologic cancer	6.01e-05	0.000275	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisolone—hematologic cancer	5.97e-05	0.000273	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—hematologic cancer	5.92e-05	0.000271	CcSEcCtD
Neostigmine—Urticaria—Triamcinolone—hematologic cancer	5.92e-05	0.000271	CcSEcCtD
Neostigmine—Asthenia—Etoposide—hematologic cancer	5.89e-05	0.000269	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—hematologic cancer	5.89e-05	0.000269	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisone—hematologic cancer	5.88e-05	0.000269	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—hematologic cancer	5.88e-05	0.000269	CcSEcCtD
Neostigmine—Nausea—Irinotecan—hematologic cancer	5.86e-05	0.000268	CcSEcCtD
Neostigmine—Nausea—Mitoxantrone—hematologic cancer	5.86e-05	0.000268	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—hematologic cancer	5.84e-05	0.000267	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.83e-05	0.000267	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.83e-05	0.000267	CcSEcCtD
Neostigmine—Pruritus—Etoposide—hematologic cancer	5.81e-05	0.000266	CcSEcCtD
Neostigmine—Shock—Prednisone—hematologic cancer	5.79e-05	0.000265	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—hematologic cancer	5.79e-05	0.000265	CcSEcCtD
Neostigmine—Nervous system disorder—Prednisone—hematologic cancer	5.77e-05	0.000264	CcSEcCtD
Neostigmine—Tachycardia—Prednisone—hematologic cancer	5.74e-05	0.000263	CcSEcCtD
Neostigmine—Skin disorder—Prednisone—hematologic cancer	5.72e-05	0.000261	CcSEcCtD
Neostigmine—Nausea—Gemcitabine—hematologic cancer	5.71e-05	0.000261	CcSEcCtD
Neostigmine—Vomiting—Cisplatin—hematologic cancer	5.7e-05	0.000261	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisone—hematologic cancer	5.69e-05	0.00026	CcSEcCtD
Neostigmine—Mental disorder—Epirubicin—hematologic cancer	5.68e-05	0.00026	CcSEcCtD
Neostigmine—Rash—Cisplatin—hematologic cancer	5.65e-05	0.000258	CcSEcCtD
Neostigmine—Dermatitis—Cisplatin—hematologic cancer	5.65e-05	0.000258	CcSEcCtD
Neostigmine—Diarrhoea—Etoposide—hematologic cancer	5.62e-05	0.000257	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—hematologic cancer	5.56e-05	0.000254	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—hematologic cancer	5.56e-05	0.000254	CcSEcCtD
Neostigmine—Gastrointestinal pain—Betamethasone—hematologic cancer	5.53e-05	0.000253	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.53e-05	0.000253	CcSEcCtD
Neostigmine—Hypersensitivity—Triamcinolone—hematologic cancer	5.49e-05	0.000251	CcSEcCtD
Neostigmine—Dizziness—Etoposide—hematologic cancer	5.43e-05	0.000248	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—hematologic cancer	5.42e-05	0.000248	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—hematologic cancer	5.4e-05	0.000247	CcSEcCtD
Neostigmine—Urticaria—Betamethasone—hematologic cancer	5.37e-05	0.000246	CcSEcCtD
Neostigmine—Urticaria—Dexamethasone—hematologic cancer	5.37e-05	0.000246	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.36e-05	0.000245	CcSEcCtD
Neostigmine—Dizziness—Prednisolone—hematologic cancer	5.35e-05	0.000245	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—hematologic cancer	5.35e-05	0.000245	CcSEcCtD
Neostigmine—Asthenia—Triamcinolone—hematologic cancer	5.34e-05	0.000244	CcSEcCtD
Neostigmine—Abdominal pain—Dexamethasone—hematologic cancer	5.34e-05	0.000244	CcSEcCtD
Neostigmine—Abdominal pain—Betamethasone—hematologic cancer	5.34e-05	0.000244	CcSEcCtD
Neostigmine—Nausea—Cisplatin—hematologic cancer	5.32e-05	0.000243	CcSEcCtD
Neostigmine—Insomnia—Prednisone—hematologic cancer	5.32e-05	0.000243	CcSEcCtD
Neostigmine—Pruritus—Triamcinolone—hematologic cancer	5.27e-05	0.000241	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—hematologic cancer	5.25e-05	0.00024	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—hematologic cancer	5.22e-05	0.000239	CcSEcCtD
Neostigmine—Vomiting—Etoposide—hematologic cancer	5.22e-05	0.000239	CcSEcCtD
Neostigmine—Agitation—Epirubicin—hematologic cancer	5.18e-05	0.000237	CcSEcCtD
Neostigmine—Rash—Etoposide—hematologic cancer	5.18e-05	0.000237	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—hematologic cancer	5.17e-05	0.000237	CcSEcCtD
Neostigmine—Headache—Etoposide—hematologic cancer	5.14e-05	0.000235	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—hematologic cancer	5.14e-05	0.000235	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—hematologic cancer	5.13e-05	0.000235	CcSEcCtD
Neostigmine—Rash—Prednisolone—hematologic cancer	5.11e-05	0.000234	CcSEcCtD
Neostigmine—Dermatitis—Prednisolone—hematologic cancer	5.1e-05	0.000233	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.09e-05	0.000233	CcSEcCtD
Neostigmine—Headache—Prednisolone—hematologic cancer	5.07e-05	0.000232	CcSEcCtD
Neostigmine—Syncope—Epirubicin—hematologic cancer	5.06e-05	0.000231	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—hematologic cancer	5.02e-05	0.000229	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—hematologic cancer	4.96e-05	0.000227	CcSEcCtD
Neostigmine—Dizziness—Triamcinolone—hematologic cancer	4.92e-05	0.000225	CcSEcCtD
Neostigmine—Anaphylactic shock—Methotrexate—hematologic cancer	4.92e-05	0.000225	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—hematologic cancer	4.89e-05	0.000223	CcSEcCtD
Neostigmine—Nausea—Etoposide—hematologic cancer	4.88e-05	0.000223	CcSEcCtD
Neostigmine—Asthenia—Dexamethasone—hematologic cancer	4.85e-05	0.000222	CcSEcCtD
Neostigmine—Asthenia—Betamethasone—hematologic cancer	4.85e-05	0.000222	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—hematologic cancer	4.82e-05	0.000221	CcSEcCtD
Neostigmine—Gastrointestinal pain—Prednisone—hematologic cancer	4.81e-05	0.00022	CcSEcCtD
Neostigmine—Nausea—Prednisolone—hematologic cancer	4.81e-05	0.00022	CcSEcCtD
Neostigmine—Arthralgia—Epirubicin—hematologic cancer	4.8e-05	0.00022	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—hematologic cancer	4.79e-05	0.000219	CcSEcCtD
Neostigmine—Pruritus—Dexamethasone—hematologic cancer	4.78e-05	0.000219	CcSEcCtD
Neostigmine—Pruritus—Betamethasone—hematologic cancer	4.78e-05	0.000219	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—hematologic cancer	4.78e-05	0.000218	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.77e-05	0.000218	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—hematologic cancer	4.75e-05	0.000217	CcSEcCtD
Neostigmine—Vomiting—Triamcinolone—hematologic cancer	4.73e-05	0.000217	CcSEcCtD
Neostigmine—Rash—Triamcinolone—hematologic cancer	4.7e-05	0.000215	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—hematologic cancer	4.7e-05	0.000215	CcSEcCtD
Neostigmine—Dermatitis—Triamcinolone—hematologic cancer	4.69e-05	0.000215	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—hematologic cancer	4.68e-05	0.000214	CcSEcCtD
Neostigmine—Urticaria—Prednisone—hematologic cancer	4.67e-05	0.000214	CcSEcCtD
Neostigmine—Headache—Triamcinolone—hematologic cancer	4.67e-05	0.000213	CcSEcCtD
Neostigmine—Abdominal pain—Prednisone—hematologic cancer	4.65e-05	0.000213	CcSEcCtD
Neostigmine—Diarrhoea—Dexamethasone—hematologic cancer	4.62e-05	0.000211	CcSEcCtD
Neostigmine—Diarrhoea—Betamethasone—hematologic cancer	4.62e-05	0.000211	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—hematologic cancer	4.6e-05	0.00021	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—hematologic cancer	4.6e-05	0.00021	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—hematologic cancer	4.59e-05	0.00021	CcSEcCtD
Neostigmine—Shock—Epirubicin—hematologic cancer	4.53e-05	0.000207	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—hematologic cancer	4.52e-05	0.000207	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—hematologic cancer	4.51e-05	0.000206	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—hematologic cancer	4.49e-05	0.000205	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.48e-05	0.000205	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—hematologic cancer	4.47e-05	0.000204	CcSEcCtD
Neostigmine—Dizziness—Betamethasone—hematologic cancer	4.47e-05	0.000204	CcSEcCtD
Neostigmine—Dizziness—Dexamethasone—hematologic cancer	4.47e-05	0.000204	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—hematologic cancer	4.45e-05	0.000203	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—hematologic cancer	4.45e-05	0.000203	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—hematologic cancer	4.44e-05	0.000203	CcSEcCtD
Neostigmine—Nausea—Triamcinolone—hematologic cancer	4.42e-05	0.000202	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.41e-05	0.000202	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—hematologic cancer	4.38e-05	0.000201	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—hematologic cancer	4.37e-05	0.0002	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—hematologic cancer	4.34e-05	0.000199	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisone—hematologic cancer	4.34e-05	0.000198	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—hematologic cancer	4.3e-05	0.000197	CcSEcCtD
Neostigmine—Vomiting—Dexamethasone—hematologic cancer	4.3e-05	0.000197	CcSEcCtD
Neostigmine—Vomiting—Betamethasone—hematologic cancer	4.3e-05	0.000197	CcSEcCtD
Neostigmine—Rash—Betamethasone—hematologic cancer	4.26e-05	0.000195	CcSEcCtD
Neostigmine—Rash—Dexamethasone—hematologic cancer	4.26e-05	0.000195	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—hematologic cancer	4.26e-05	0.000195	CcSEcCtD
Neostigmine—Dermatitis—Dexamethasone—hematologic cancer	4.26e-05	0.000195	CcSEcCtD
Neostigmine—Dermatitis—Betamethasone—hematologic cancer	4.26e-05	0.000195	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.25e-05	0.000194	CcSEcCtD
Neostigmine—Headache—Betamethasone—hematologic cancer	4.23e-05	0.000194	CcSEcCtD
Neostigmine—Headache—Dexamethasone—hematologic cancer	4.23e-05	0.000194	CcSEcCtD
Neostigmine—Asthenia—Prednisone—hematologic cancer	4.22e-05	0.000193	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.19e-05	0.000192	CcSEcCtD
Neostigmine—Shock—Doxorubicin—hematologic cancer	4.19e-05	0.000192	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—hematologic cancer	4.18e-05	0.000191	CcSEcCtD
Neostigmine—Pruritus—Prednisone—hematologic cancer	4.16e-05	0.00019	CcSEcCtD
Neostigmine—Insomnia—Epirubicin—hematologic cancer	4.16e-05	0.00019	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—hematologic cancer	4.16e-05	0.00019	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—hematologic cancer	4.14e-05	0.000189	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—hematologic cancer	4.12e-05	0.000188	CcSEcCtD
Neostigmine—Dyspnoea—Epirubicin—hematologic cancer	4.1e-05	0.000188	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—hematologic cancer	4.09e-05	0.000187	CcSEcCtD
Neostigmine—Diarrhoea—Prednisone—hematologic cancer	4.03e-05	0.000184	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methotrexate—hematologic cancer	4.02e-05	0.000184	CcSEcCtD
Neostigmine—Nausea—Dexamethasone—hematologic cancer	4.01e-05	0.000184	CcSEcCtD
Neostigmine—Nausea—Betamethasone—hematologic cancer	4.01e-05	0.000184	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—hematologic cancer	3.98e-05	0.000182	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.97e-05	0.000182	CcSEcCtD
Neostigmine—Urticaria—Methotrexate—hematologic cancer	3.91e-05	0.000179	CcSEcCtD
Neostigmine—Dizziness—Prednisone—hematologic cancer	3.89e-05	0.000178	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—hematologic cancer	3.89e-05	0.000178	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.88e-05	0.000177	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—hematologic cancer	3.85e-05	0.000176	CcSEcCtD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	3.83e-05	0.000602	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL1B—hematologic cancer	3.82e-05	0.000601	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—HSPA5—hematologic cancer	3.82e-05	0.000601	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP3—hematologic cancer	3.82e-05	0.0006	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL2—hematologic cancer	3.81e-05	0.000599	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—BRAF—hematologic cancer	3.8e-05	0.000598	CbGpPWpGaD
Neostigmine—Dyspnoea—Doxorubicin—hematologic cancer	3.8e-05	0.000174	CcSEcCtD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	3.79e-05	0.000596	CbGpPWpGaD
Neostigmine—Somnolence—Doxorubicin—hematologic cancer	3.79e-05	0.000173	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.77e-05	0.000593	CbGpPWpGaD
Neostigmine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.76e-05	0.000172	CcSEcCtD
Neostigmine—Vomiting—Prednisone—hematologic cancer	3.74e-05	0.000171	CcSEcCtD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	3.74e-05	0.000588	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—hematologic cancer	3.72e-05	0.000585	CbGpPWpGaD
Neostigmine—Rash—Prednisone—hematologic cancer	3.71e-05	0.00017	CcSEcCtD
Neostigmine—Dermatitis—Prednisone—hematologic cancer	3.71e-05	0.00017	CcSEcCtD
Neostigmine—BCHE—Metabolism of proteins—CALR—hematologic cancer	3.7e-05	0.000582	CbGpPWpGaD
Neostigmine—Headache—Prednisone—hematologic cancer	3.69e-05	0.000169	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.68e-05	0.000168	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.67e-05	0.000577	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—IDH2—hematologic cancer	3.66e-05	0.000575	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMMR—hematologic cancer	3.66e-05	0.000575	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.66e-05	0.000575	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.66e-05	0.000575	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.66e-05	0.000575	CbGpPWpGaD
Neostigmine—Urticaria—Epirubicin—hematologic cancer	3.66e-05	0.000167	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—hematologic cancer	3.64e-05	0.000166	CcSEcCtD
Neostigmine—Hypersensitivity—Methotrexate—hematologic cancer	3.62e-05	0.000166	CcSEcCtD
Neostigmine—BCHE—Metabolism of proteins—FBXW7—hematologic cancer	3.58e-05	0.000563	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MDM2—hematologic cancer	3.57e-05	0.000561	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	3.56e-05	0.000559	CbGpPWpGaD
Neostigmine—Asthenia—Methotrexate—hematologic cancer	3.53e-05	0.000161	CcSEcCtD
Neostigmine—BCHE—Metabolism—FHL2—hematologic cancer	3.51e-05	0.000552	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	3.51e-05	0.000551	CbGpPWpGaD
Neostigmine—Nausea—Prednisone—hematologic cancer	3.5e-05	0.00016	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.48e-05	0.000159	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—hematologic cancer	3.48e-05	0.000159	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.47e-05	0.000546	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.45e-05	0.000543	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	3.45e-05	0.000542	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AGRN—hematologic cancer	3.44e-05	0.000542	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ARNTL—hematologic cancer	3.44e-05	0.000541	CbGpPWpGaD
Neostigmine—Hypersensitivity—Epirubicin—hematologic cancer	3.39e-05	0.000155	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—hematologic cancer	3.38e-05	0.000155	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.38e-05	0.000531	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.37e-05	0.00053	CbGpPWpGaD
Neostigmine—Abdominal pain—Doxorubicin—hematologic cancer	3.37e-05	0.000154	CcSEcCtD
Neostigmine—Diarrhoea—Methotrexate—hematologic cancer	3.36e-05	0.000154	CcSEcCtD
Neostigmine—ACHE—Metabolism—CA9—hematologic cancer	3.35e-05	0.000526	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ACP5—hematologic cancer	3.35e-05	0.000526	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	3.34e-05	0.000526	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—hematologic cancer	3.32e-05	0.000522	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOR2—hematologic cancer	3.3e-05	0.000519	CbGpPWpGaD
Neostigmine—Asthenia—Epirubicin—hematologic cancer	3.3e-05	0.000151	CcSEcCtD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	3.29e-05	0.000518	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—IDH2—hematologic cancer	3.27e-05	0.000513	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMMR—hematologic cancer	3.27e-05	0.000513	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GMPS—hematologic cancer	3.26e-05	0.000513	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PHYH—hematologic cancer	3.26e-05	0.000513	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FTCD—hematologic cancer	3.26e-05	0.000513	CbGpPWpGaD
Neostigmine—Pruritus—Epirubicin—hematologic cancer	3.26e-05	0.000149	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—hematologic cancer	3.25e-05	0.000149	CcSEcCtD
Neostigmine—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	3.24e-05	0.000509	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	3.23e-05	0.000507	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MDM2—hematologic cancer	3.18e-05	0.000501	CbGpPWpGaD
Neostigmine—Diarrhoea—Epirubicin—hematologic cancer	3.15e-05	0.000144	CcSEcCtD
Neostigmine—ACHE—Metabolism—IDH1—hematologic cancer	3.15e-05	0.000495	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	3.15e-05	0.000495	CbGpPWpGaD
Neostigmine—Hypersensitivity—Doxorubicin—hematologic cancer	3.14e-05	0.000143	CcSEcCtD
Neostigmine—Vomiting—Methotrexate—hematologic cancer	3.13e-05	0.000143	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	3.12e-05	0.000491	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TXN—hematologic cancer	3.11e-05	0.000489	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCC3—hematologic cancer	3.11e-05	0.000489	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTO1—hematologic cancer	3.11e-05	0.000489	CbGpPWpGaD
Neostigmine—Rash—Methotrexate—hematologic cancer	3.1e-05	0.000142	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—hematologic cancer	3.1e-05	0.000142	CcSEcCtD
Neostigmine—Headache—Methotrexate—hematologic cancer	3.08e-05	0.000141	CcSEcCtD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.08e-05	0.000484	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ARNTL—hematologic cancer	3.07e-05	0.000483	CbGpPWpGaD
Neostigmine—Asthenia—Doxorubicin—hematologic cancer	3.06e-05	0.00014	CcSEcCtD
Neostigmine—ACHE—Metabolism—SPHK1—hematologic cancer	3.05e-05	0.000479	CbGpPWpGaD
Neostigmine—Dizziness—Epirubicin—hematologic cancer	3.04e-05	0.000139	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—hematologic cancer	3.01e-05	0.000138	CcSEcCtD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	3e-05	0.000472	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ACP5—hematologic cancer	2.99e-05	0.00047	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CA9—hematologic cancer	2.99e-05	0.00047	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SMPD3—hematologic cancer	2.98e-05	0.000469	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	2.97e-05	0.000467	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOR2—hematologic cancer	2.95e-05	0.000463	CbGpPWpGaD
Neostigmine—Vomiting—Epirubicin—hematologic cancer	2.93e-05	0.000134	CcSEcCtD
Neostigmine—ACHE—Metabolism—UGT1A1—hematologic cancer	2.93e-05	0.00046	CbGpPWpGaD
Neostigmine—Nausea—Methotrexate—hematologic cancer	2.92e-05	0.000134	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—hematologic cancer	2.91e-05	0.000133	CcSEcCtD
Neostigmine—Rash—Epirubicin—hematologic cancer	2.9e-05	0.000133	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—hematologic cancer	2.9e-05	0.000133	CcSEcCtD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.89e-05	0.000455	CbGpPWpGaD
Neostigmine—Headache—Epirubicin—hematologic cancer	2.88e-05	0.000132	CcSEcCtD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	2.88e-05	0.000453	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.87e-05	0.000451	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	2.85e-05	0.000448	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC22A1—hematologic cancer	2.85e-05	0.000448	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CRABP1—hematologic cancer	2.85e-05	0.000448	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	2.84e-05	0.000446	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	2.83e-05	0.000444	CbGpPWpGaD
Neostigmine—Dizziness—Doxorubicin—hematologic cancer	2.82e-05	0.000129	CcSEcCtD
Neostigmine—BCHE—Metabolism—IDH1—hematologic cancer	2.81e-05	0.000441	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TXN—hematologic cancer	2.78e-05	0.000437	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTO1—hematologic cancer	2.78e-05	0.000437	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCC3—hematologic cancer	2.78e-05	0.000437	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TNF—hematologic cancer	2.77e-05	0.000436	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALOX5—hematologic cancer	2.77e-05	0.000436	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.77e-05	0.000436	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	2.76e-05	0.000434	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	2.76e-05	0.000434	CbGpPWpGaD
Neostigmine—Nausea—Epirubicin—hematologic cancer	2.73e-05	0.000125	CcSEcCtD
Neostigmine—BCHE—Metabolism—SPHK1—hematologic cancer	2.72e-05	0.000427	CbGpPWpGaD
Neostigmine—Vomiting—Doxorubicin—hematologic cancer	2.71e-05	0.000124	CcSEcCtD
Neostigmine—ACHE—Metabolism—NUP98—hematologic cancer	2.69e-05	0.000422	CbGpPWpGaD
Neostigmine—Rash—Doxorubicin—hematologic cancer	2.68e-05	0.000123	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—hematologic cancer	2.68e-05	0.000123	CcSEcCtD
Neostigmine—Headache—Doxorubicin—hematologic cancer	2.67e-05	0.000122	CcSEcCtD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.65e-05	0.000416	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—UGT1A1—hematologic cancer	2.61e-05	0.00041	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADCY7—hematologic cancer	2.61e-05	0.00041	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA3—hematologic cancer	2.61e-05	0.00041	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—B3GAT1—hematologic cancer	2.61e-05	0.00041	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ASNS—hematologic cancer	2.61e-05	0.00041	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DCK—hematologic cancer	2.61e-05	0.00041	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NUP214—hematologic cancer	2.59e-05	0.000407	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.56e-05	0.000403	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.56e-05	0.000402	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	2.54e-05	0.0004	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC22A1—hematologic cancer	2.54e-05	0.000399	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CRABP1—hematologic cancer	2.54e-05	0.000399	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCG2—hematologic cancer	2.54e-05	0.000399	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTR—hematologic cancer	2.54e-05	0.000399	CbGpPWpGaD
Neostigmine—Nausea—Doxorubicin—hematologic cancer	2.53e-05	0.000116	CcSEcCtD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.5e-05	0.000393	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	2.49e-05	0.000391	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ENO2—hematologic cancer	2.49e-05	0.000391	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	2.48e-05	0.000389	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALOX5—hematologic cancer	2.47e-05	0.000389	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HDC—hematologic cancer	2.47e-05	0.000389	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.42e-05	0.000381	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—hematologic cancer	2.41e-05	0.000379	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.41e-05	0.000378	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NUP98—hematologic cancer	2.4e-05	0.000377	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	2.39e-05	0.000375	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.38e-05	0.000374	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	2.36e-05	0.000372	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SDC1—hematologic cancer	2.36e-05	0.000371	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.36e-05	0.000371	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.34e-05	0.000368	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADCY7—hematologic cancer	2.33e-05	0.000366	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA3—hematologic cancer	2.33e-05	0.000366	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NUP214—hematologic cancer	2.31e-05	0.000363	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.29e-05	0.000359	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.28e-05	0.000359	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCG2—hematologic cancer	2.26e-05	0.000356	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTR—hematologic cancer	2.26e-05	0.000356	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CDA—hematologic cancer	2.26e-05	0.000356	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.25e-05	0.000354	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	2.25e-05	0.000354	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.22e-05	0.00035	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ENO2—hematologic cancer	2.22e-05	0.000349	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PC—hematologic cancer	2.18e-05	0.000342	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—hematologic cancer	2.15e-05	0.000338	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	2.14e-05	0.000336	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.13e-05	0.000335	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.12e-05	0.000333	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SDC1—hematologic cancer	2.1e-05	0.000331	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	2.1e-05	0.000331	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GBA—hematologic cancer	2.1e-05	0.000331	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC35B2—hematologic cancer	2.1e-05	0.000331	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.1e-05	0.00033	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CCL2—hematologic cancer	2.06e-05	0.000324	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.01e-05	0.000316	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CD44—hematologic cancer	2.01e-05	0.000315	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NQO1—hematologic cancer	2.01e-05	0.000315	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.98e-05	0.000312	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.96e-05	0.000309	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—HRAS—hematologic cancer	1.96e-05	0.000308	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTAP—hematologic cancer	1.92e-05	0.000302	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.92e-05	0.000302	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.9e-05	0.000298	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYCS—hematologic cancer	1.9e-05	0.000298	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HSP90AA1—hematologic cancer	1.89e-05	0.000296	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.88e-05	0.000296	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CCL2—hematologic cancer	1.84e-05	0.000289	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.83e-05	0.000288	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.83e-05	0.000288	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NQO1—hematologic cancer	1.79e-05	0.000281	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CD44—hematologic cancer	1.79e-05	0.000281	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.77e-05	0.000279	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.77e-05	0.000278	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.76e-05	0.000277	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.75e-05	0.000275	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—HRAS—hematologic cancer	1.75e-05	0.000275	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.73e-05	0.000272	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FHL2—hematologic cancer	1.71e-05	0.000269	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.7e-05	0.000267	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYCS—hematologic cancer	1.69e-05	0.000266	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.69e-05	0.000265	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HSP90AA1—hematologic cancer	1.68e-05	0.000264	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AGRN—hematologic cancer	1.68e-05	0.000264	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—hematologic cancer	1.67e-05	0.000263	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.64e-05	0.000258	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.62e-05	0.000254	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.6e-05	0.000251	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—IDH2—hematologic cancer	1.59e-05	0.000251	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMMR—hematologic cancer	1.59e-05	0.000251	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCB1—hematologic cancer	1.58e-05	0.000249	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—hematologic cancer	1.54e-05	0.000242	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOR1—hematologic cancer	1.54e-05	0.000242	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.51e-05	0.000238	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.51e-05	0.000238	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ARNTL—hematologic cancer	1.5e-05	0.000236	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—hematologic cancer	1.49e-05	0.000235	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.47e-05	0.000231	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.47e-05	0.000231	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA9—hematologic cancer	1.46e-05	0.000229	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACP5—hematologic cancer	1.46e-05	0.000229	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.44e-05	0.000227	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOR2—hematologic cancer	1.44e-05	0.000226	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCB1—hematologic cancer	1.41e-05	0.000222	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOR1—hematologic cancer	1.37e-05	0.000216	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—hematologic cancer	1.37e-05	0.000216	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—IDH1—hematologic cancer	1.37e-05	0.000215	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.37e-05	0.000215	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTHFR—hematologic cancer	1.36e-05	0.000214	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.36e-05	0.000214	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTO1—hematologic cancer	1.35e-05	0.000213	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TXN—hematologic cancer	1.35e-05	0.000213	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCC3—hematologic cancer	1.35e-05	0.000213	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SPHK1—hematologic cancer	1.33e-05	0.000208	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.27e-05	0.0002	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.25e-05	0.000196	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.24e-05	0.000195	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CRABP1—hematologic cancer	1.24e-05	0.000195	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTHFR—hematologic cancer	1.21e-05	0.000191	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALOX5—hematologic cancer	1.21e-05	0.00019	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.21e-05	0.00019	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.2e-05	0.000188	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NUP98—hematologic cancer	1.17e-05	0.000184	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—hematologic cancer	1.14e-05	0.000179	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADCY7—hematologic cancer	1.14e-05	0.000178	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA3—hematologic cancer	1.14e-05	0.000178	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NUP214—hematologic cancer	1.13e-05	0.000177	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCG2—hematologic cancer	1.1e-05	0.000174	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTR—hematologic cancer	1.1e-05	0.000174	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENO2—hematologic cancer	1.08e-05	0.00017	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.07e-05	0.000168	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CREBBP—hematologic cancer	1.06e-05	0.000166	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—hematologic cancer	1.05e-05	0.000165	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SDC1—hematologic cancer	1.03e-05	0.000161	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.02e-05	0.00016	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—hematologic cancer	1.02e-05	0.00016	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—hematologic cancer	1e-05	0.000158	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—hematologic cancer	9.9e-06	0.000156	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.83e-06	0.000155	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3R1—hematologic cancer	9.47e-06	0.000149	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CREBBP—hematologic cancer	9.44e-06	0.000148	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	9.2e-06	0.000145	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—hematologic cancer	8.95e-06	0.000141	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—hematologic cancer	8.84e-06	0.000139	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—hematologic cancer	8.75e-06	0.000138	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CD44—hematologic cancer	8.73e-06	0.000137	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NQO1—hematologic cancer	8.73e-06	0.000137	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3R1—hematologic cancer	8.45e-06	0.000133	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYCS—hematologic cancer	8.26e-06	0.00013	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	8.21e-06	0.000129	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—hematologic cancer	7.8e-06	0.000123	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTEN—hematologic cancer	7.56e-06	0.000119	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—hematologic cancer	7.28e-06	0.000114	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—EP300—hematologic cancer	7.21e-06	0.000113	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTEN—hematologic cancer	6.74e-06	0.000106	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—hematologic cancer	6.69e-06	0.000105	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOR1—hematologic cancer	6.69e-06	0.000105	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—EP300—hematologic cancer	6.43e-06	0.000101	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTHFR—hematologic cancer	5.91e-06	9.3e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—hematologic cancer	5.33e-06	8.38e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.97e-06	7.81e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—hematologic cancer	4.76e-06	7.48e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CREBBP—hematologic cancer	4.61e-06	7.24e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.37e-06	6.87e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—hematologic cancer	4.36e-06	6.85e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—hematologic cancer	4.31e-06	6.78e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3R1—hematologic cancer	4.12e-06	6.48e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—hematologic cancer	3.89e-06	6.11e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.81e-06	5.99e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTEN—hematologic cancer	3.29e-06	5.17e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—EP300—hematologic cancer	3.14e-06	4.93e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.32e-06	3.65e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—hematologic cancer	1.9e-06	2.98e-05	CbGpPWpGaD
